首页|血清脂蛋白(a)与慢性肾脏病恶化进展的相关性及危险因素分析

血清脂蛋白(a)与慢性肾脏病恶化进展的相关性及危险因素分析

扫码查看
目的 探究血清脂蛋白(a)[Lp(a)]与慢性肾脏病(CKD)患者恶化进展的相关性,明确Lp(a)预测CKD病情进展的价值及筛选影响CKD进展的危险因素.方法 选取2019年6月至2023年10月就诊于西安交通大学第二附属医院的CKD患者866例为CKD病例组,同期本院健康查体者84例为健康对照组.免疫比浊法检测血清Lp(a)水平,酶比色法检测血清脂质代谢及肾脏功能指标:总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、载脂蛋白A(ApoA)、载脂蛋白B(ApoB)、肌酐(CREA)、胱抑素C(CysC)、尿素(UREA)、尿酸(URIC)及肾小球滤过率(eGFR)水平.结果 CKD病例组血清Lp(a)水平显著高于健康对照组,差异有统计学意义(P<0.01).Lp(a)及其他血脂指标TC、HDL、LDL、ApoA及ApoB在不同分期CKD病例组中差异也均有统计学意义(P均<0.01).相关性分析显示,1~5期CKD病例组血清Lp(a)水平随CKD分级增高而上升,二者呈正相关(r=0.938,P<0.05).ROC曲线分析显示,血清Lp(a)的最佳截断值为13.45mg/dL,预测CKD进展的曲线下面积为0.732,灵敏度为67.47%,特异性为67.27%.Logistic回归分析显示,Lp(a)、ApoA、CysC及UREA是CKD进展的独立危险因素(P均<0.05),HDL、ApoB、CREA及eGFR是CKD进展的保护因素(P均<0.05).结论 血清Lp(a)升高是CKD恶化进展的独立危险因素,Lp(a)水平与CKD分期密切相关,对控制CKD恶化进展、延缓终末期肾衰竭及提高CKD患者生存率具有重要意义.
The Correlation Between Serum Lipoprotein(a)and the Progression of Chronic Kidney Disease with the Exploration of Risk Factors
Objective To investigate the correlation between serum lipoprotein(a)[Lipoprotein(a),Lp(a)]and the progression of chronic kidney disease(Chronic kidney disease,CKD),so as to evaluate the value of Lp(a)in predicting the progression of CKD,and to further identify risk factors that influence CKD progression.Methods A total of 866 CKD patients who were admitted to the Second Affiliated Hospital of Xi'an Jiaotong University from June,2019 to October,2023 were selected as the CKD group,while 84 healthy individuals who underwent physical examination in our hospital during the same period were selected as the healthy control group.Serum Lp(a)levels were measured by the immunoturbidimetric technique.Serum lipid metabolism and renal function indicators,including total cholesterol(TC),triglycerides(TG),high-density lipoprotein(HDL),low-density lipoprotein(LDL),apolipoprotein A(ApoA),apolipoprotein B(ApoB),creatinine(CREA),cystatin C(CysC),urea(UREA),uric acid(URIC),and estimated glomerular filtration rate(eGFR),were detected by the enzyme colorimetric method.Results The serum Lp(a)level in the CKD group was significantly higher than that in the healthy control group(P<0.01).There were also significant differences in Lp(a)and other blood lipid indicators,such as TC,HDL,LDL,ApoA,and ApoB,among different stages of CKD groups(all P<0.01).Correlation analysis showed that the serum Lp(a)level in stage 1-5 CKD group increased,and they were positively correlated(r=0.938,P<0.05).ROC curve analysis showed that the optimal cutoff value of serum Lp(a)was 13.45 mg/dL.The area under ROC curve(AUC)for predicting CKD progression was 0.732,with the sensitivity of 67.47%,and the specificity of 67.27%.Logistic regression analysis showed that Lp(a),ApoA,CysC,and UREA were independent risk factors for the progression of CKD(all P<0.05).Furthermore,HDL,ApoB,CREA,and eGFR were protective factors for the progression of CKD(all P<0.05).Conclusion Elevated serum Lp(a)is an independent risk factor for the progression of CKD.Lp(a)level is closely related to the CKD stages,which is of great significance for controlling CKD progression,delaying end-stage renal failure,and improving the survival rate of CKD patients.

Chronic kidney diseaseLipoprotein(a)Lipid metabolismKidney function

马小东、钟瑜、郑向红、吴金鑫、葛壮、吴涛、乔二悦、狄佳

展开 >

西安交通大学第二附属医院核医学科,陕西西安 710004

西安交通大学第二附属医院检验科,陕西西安 710004

慢性肾脏病 脂蛋白(a) 血脂代谢 肾脏功能

中国博士后科学基金面上项目陕西省自然科学基金基础研究计划青年项目西安交通大学第二附属医院医疗新技术

2022M7125562022JQ-838XJEFY-015

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(8)